The Copenhagen-based firm invests in seed, early, and later-stage healthcare and life sciences companies in Europe and the United States. Sound Bioventures focuses on private clinical stage biotherapeutics companies and supports the development of new medicines for diseases with high unmet medical needs. The firm's geographic footprint spans both sides of the Atlantic.